NCT04405557View on ClinicalTrials.gov

The PREDICT Study: Prospective Early Detection In a Population at High-risk for Common Malignant Tumor

Active, not recruitingOBSERVATIONAL
Enrollment

757

Participants

Timeline

Start Date

November 12, 2019

Primary Completion Date

January 16, 2022

Study Completion Date

December 31, 2026

Conditions
Early Detection of Cancer
Trial Locations (8)

121001

The First Affiliated Hospital of Jinzhou Medical University, Jinzhou

130033

China-Japan Union Hospital of Jilin University, Changchun

210029

Jiangsu Province Hospital, Nanjing

410008

Xiangya Hospital Central South University, Changsha

450003

Henan Provincial People's Hospital, Zhengzhou

518020

Shenzhen People's Hospital, Shenzhen

610072

Sichuan Provincial People's Hospital, Chengdu

Unknown

Chinese PLA General Hospital, Beijing

All Listed Sponsors
collaborator

Chinese PLA General Hospital

OTHER

lead

Geneplus-Beijing Co. Ltd.

INDUSTRY

NCT04405557 - The PREDICT Study: Prospective Early Detection In a Population at High-risk for Common Malignant Tumor | Biotech Hunter | Biotech Hunter